Matijašić M, Meštrović T, Perić M, ČipčićPaljetak H, Panek M, Vranešić Bender D, LjubasKelečić D, Krznarić Ž, Verbanac D (2016) Modulating composition and metabolic activity of the gut microbiota in IBD patients. Int J Mol Sci 17. https://doi.org/10.3390/ijms17040578

Napolitano M, Fasulo E, Ungaro F, Massimino L, Sinagra E, Danese S, Mandarino FV (2023) Gut dysbiosis in irritable bowel syndrome: a narrative review on correlation with disease subtypes and novel therapeutic implications. Microorganisms 11:2369

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL et al (2018) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778. https://doi.org/10.1016/s0140-6736(17)32448-0

Article  Google Scholar 

Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC (2020) Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5:908–917. https://doi.org/10.1016/s2468-1253(20)30217-x

Article  PubMed  Google Scholar 

Khaki-Khatibi F, Qujeq D, Kashifard M, Moein S, Maniati M, Vaghari-Tabari M (2020) Calprotectin in inflammatory bowel disease. Clin Chim Acta 510:556–565. https://doi.org/10.1016/j.cca.2020.08.025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Assarsson E, Lundberg M, Holmquist G, Björkesten J, Thorsen SB, Ekman D, Eriksson A, Rennel Dickens E, Ohlsson S, Edfeldt G et al (2014) Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9:e95192. https://doi.org/10.1371/journal.pone.0095192

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bennet SM, Polster A, Törnblom H, Isaksson S, Capronnier S, Tessier A, Le Nevé B, Simrén M, Öhman L (2016) Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome. Am J Gastroenterol 111:1165–1176. https://doi.org/10.1038/ajg.2016.223

Article  CAS  PubMed  Google Scholar 

Kalla R, Adams AT, Bergemalm D, Vatn S, Kennedy NA, Ricanek P, Lindstrom J, Ocklind A, Hjelm F, Ventham NT et al (2021) Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. J Crohns Colitis 15:699–708. https://doi.org/10.1093/ecco-jcc/jjaa230

Article  CAS  PubMed  Google Scholar 

Moraes L, Magnusson MK, Mavroudis G, Polster A, Jonefjäll B, Törnblom H, Sundin J, Simrén M, Strid H, Öhman L (2020) Systemic inflammatory protein profiles distinguish irritable bowel syndrome (IBS) and ulcerative colitis, irrespective of inflammation or IBS-like symptoms. Inflamm Bowel Dis 26:874–884. https://doi.org/10.1093/ibd/izz322

Article  PubMed  PubMed Central  Google Scholar 

Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C et al (2020) Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character). Scand J Gastroent 55:1146–1156. https://doi.org/10.1080/00365521.2020.1803396

Article  CAS  PubMed  Google Scholar 

Sehgal R, Koltun WA (2010) Scoring systems in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 4:513–521. https://doi.org/10.1586/egh.10.40

Article  PubMed  Google Scholar 

Drossman DA, Dumitrascu DL (2006) Rome III: new standard for functional gastrointestinal disorders. J Gastrointestin Liver Dis 15:237–241

PubMed  Google Scholar 

Čipčić Paljetak H, Barešić A, Panek M, Perić M, Matijašić M, Lojkić I, Barišić A, Vranešić Bender D, Ljubas Kelečić D, Brinar M et al (2022) Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients. Gut Microbes 14:2083419. https://doi.org/10.1080/19490976.2022.2083419

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI et al (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335–336. https://doi.org/10.1038/nmeth.f.303

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandes AD, Reid JN, Macklaim JM, McMurrough TA, Edgell DR, Gloor GB (2014) Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome 2:15. https://doi.org/10.1186/2049-2618-2-15

Article  PubMed  PubMed Central  Google Scholar 

Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J (2003) Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52:847–853. https://doi.org/10.1136/gut.52.6.847

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verstockt S, Verstockt B, Vermeire S (2019) Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD). Expert Opin Ther Targets 23:943–954. https://doi.org/10.1080/14728222.2019.1677608

Article  CAS  PubMed  Google Scholar 

Cohavy O, Zhou J, Ware CF, Targan SR (2005) LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling. J Immunol 174:646–653. https://doi.org/10.4049/jimmunol.174.2.646

Article  CAS  PubMed  Google Scholar 

Abedin N, Seemann T, Kleinfeld S, Ruehrup J, Röseler S, Trautwein C, Streetz K, Sellge G (2019) Fecal eosinophil cationic protein is a diagnostic and predictive biomarker in young adults with inflammatory bowel disease. J Clin Med 8:2025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alghoul Z, Yang C, Merlin D (2022) The current status of molecular biomarkers for inflammatory bowel disease. Biomedicines 10:1492

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Zhou Y, Sun Y, Yuan S, Kalla R, Sun J, Zhao J, Wang L, Chen X, Zhou X et al (2022) Bidirectional Mendelian randomisation analysis provides evidence for the causal involvement of dysregulation of CXCL9, CCL11 and CASP8 in the pathogenesis of ulcerative colitis. J Crohns Colitis 17:777–785. https://doi.org/10.1093/ecco-jcc/jjac191

Article  PubMed Central  Google Scholar 

Salahshor S, Woodgett JR (2005) The links between axin and carcinogenesis. J Clin Pathol 58:225–236. https://doi.org/10.1136/jcp.2003.009506

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kummola L, Hämäläinen JM, Kivelä J, Kivelä AJ, Saarnio J, Karttunen T, Parkkila S (2005) Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer 5:41. https://doi.org/10.1186/1471-2407-5-41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gray JP, Alavian KN, Jonas EA, Heart EA (2012) NAD kinase regulates the size of the NADPH pool and insulin secretion in pancreatic β-cells. Am J Physiol Endocrinol Metab 303:E191-199. https://doi.org/10.1152/ajpendo.00465.2011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Wang Z, Wang T, Cheng J, Zhuang R, Wang W (2023) SNAP23 decreases insulin secretion by competitively inhibiting the interaction between SNAP25 and STX1A. Biosci Rep 43. https://doi.org/10.1042/bsr20222594

Naderi N, Zamanian Azodi M, Daskar Abkenar E, Shahidi Dadras M, Talaei R (2018) Insulin dysregulation plays a critical role in colon inflammation: a bioinformatics approach. Gastroenterol Hepatol Bed Bench 11:S85-s91

PubMed  PubMed Central  Google Scholar 

Jurjus A, Eid A, Al Kattar S, Zeenny MN, Gerges-Geagea A, Haydar H, Hilal A, Oueidat D, Matar M, Tawilah J et al (2016) Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links. BBA Clinical 5:16–24. https://doi.org/10.1016/j.bbacli.2015.11.002

Article  PubMed  Google Scholar 

Manolakis AC, Kapsoritakis AN, Georgoulias P, Tzavara C, Valotassiou V, Kapsoritaki A, Potamianos SP (2010) Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome. BMC Gastroenterol 10:118. https://doi.org/10.1186/1471-230x-10-118

Article  PubMed  PubMed Central